FDA Drug Recalls

Recalls / Class II

Class IID-0098-2018

Product

Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01

Affected lot / code info
Lot: #:16F649, Exp: May 2018

Why it was recalled

Failed Dissolution Specifications.

Recalling firm

Firm
Mayne Pharma Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1240 Sugg Pkwy, N/A, Greenville, North Carolina 27834-9006

Distribution

Quantity
11,364 bottles
Distribution pattern
Nationwide within USA

Timeline

Recall initiated
2017-11-09
FDA classified
2017-11-29
Posted by FDA
2017-12-06
Terminated
2020-05-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0098-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.